Skip to main content

Table 2 Haplotypes according to the presence of phospholipase A2 receptor 1 (PLA2R1) single nucleotide polymorphisms (SNPs) in patients with idiopathic membranous nephropathy (IMN) vs healthy controls

From: Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan

Polymorphisms

Controls

N (%)

IMN

N (%)

p-Value

Odds ratio (95% CI)e

Haplotype a

H1-TG

84 (39.6)

134 (51.9)

0.004b

1.647 (1.140-2.379)

H2-CG

72 (34.0)

83 (32.2)

 

0.922 (0.627-1.357)

H3-TC

52 (24.5)

41 (15.9)

 

0.581 (0.368-0.919)

H4-CC

4 (1.9)

0 (0.0)

 

0.005 (0.000-)

Diplotypes a

H1/H1 + H1/nonH1

67 (63.2)

99 (76.7)

0.023c

1.921 (1.088-3.390)

H1/H1

17 (16.0)

35 (27.1)

0.031d

2.676 (1.264-5.665)

H1/nonH1

54 (47.2)

64 (49.6)

 

1.664 (0.911-3.041)

nonH1/nonH1

39 (36.8)

30 (23.3)

 

1

H2/H2 + H2/nonH2

64 (60.4)

68 (52.7)

0.239c

1.921 (1.088-3.390)

H2/H2

8 (7.5)

15 (11.6)

0.174d

2.676 (1.264-5.665)

H2/nonH2

56 (52.8)

53 (41.1)

 

1.664 (0.911-3.041)

nonH2/nonH2

42 (39.6)

61 (47.3)

 

1

H3/H3 + H3/nonH3

47 (44.3)

39 (30.2)

0.025c

0.544 (0.318-0.930)

H3/H3

5 (4.7)

2 (1.6)

0.053d

0.262 (0.049-1.396)

H3/nonH3

42 (39.6)

37 (28.7)

 

0.578 (0.333-1.002)

nonH3/nonH3

59 (55.7)

90 (69.8)

 

1

H4/H4 + H4/nonH4

4 (3.8)

0 (0.0)

0.026c

0.000 (0.000-)

H4/H4

0 (0.0)

0 (0.0)

0.026d

--

H4/nonH4

4 (3.8)

0 (0.0)

 

0.000 (0.000-)

nonH4/nonH4

102 (96.2)

129 (100.0)

 

1

  1. Abbreviations: CI, confidence interval; H, haplotype.
  2. a Order of SNPs comprising the PLA2R1 haplotypes: rs6757188, and rs35771982. The haplotypes were identified by the Baysian statistical method available in the program Phase 2.1.
  3. b The significance of haplotype frequency for IMN development was determined by chi-square test using 4 × 2 contingency tables.
  4. c Individual haplotype frequencies for IMN development were determined by chi-square test using 2 × 2 contingency tables.
  5. d The significance of diplotype frequency for IMN development were determined by chi-square test using 3 × 2 contingency tables.
  6. e Odds ratios and 95% CI per haplotype or diplotype were estimated by applying unconditional logistic regression between patients with IMN and healthy controls.